Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD

Christopher Reynolds; John Levine; Joseph Uberti; Voravit Ratanatharathorn; Lois Ayash; Samuel Silver; Gregory Yanik; Pavan Reddy; Kenneth Cooke; Michael Becker; Raymond Hutchinson; James Ferrara

Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD

Christopher Reynolds, John Levine, Joseph Uberti, Voravit Ratanatharathorn, Lois Ayash, Samuel Silver, Gregory Yanik, Pavan Reddy, Kenneth Cooke, Michael Becker, Raymond Hutchinson, James Ferrara

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	78-79
Number of pages	2
Journal	Journal of Supportive Oncology
Volume	3
Issue number	2 SUPPL. 1
State	Published - Mar 1 2005
Externally published	Yes

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Cite this

Reynolds, C., Levine, J., Uberti, J., Ratanatharathorn, V., Ayash, L., Silver, S., Yanik, G., Reddy, P., Cooke, K., Becker, M., Hutchinson, R., & Ferrara, J. (2005). Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD. Journal of Supportive Oncology, 3(2 SUPPL. 1), 78-79.

Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD. / Reynolds, Christopher; Levine, John; Uberti, Joseph et al.
In: Journal of Supportive Oncology, Vol. 3, No. 2 SUPPL. 1, 01.03.2005, p. 78-79.

Research output: Contribution to journal › Article › peer-review

Reynolds, C, Levine, J, Uberti, J, Ratanatharathorn, V, Ayash, L, Silver, S, Yanik, G, Reddy, P, Cooke, K, Becker, M, Hutchinson, R & Ferrara, J 2005, 'Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD', Journal of Supportive Oncology, vol. 3, no. 2 SUPPL. 1, pp. 78-79.

@article{8f37930dc9ba43bd98b2053ae9fd3ae4,

title = "Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD",

author = "Christopher Reynolds and John Levine and Joseph Uberti and Voravit Ratanatharathorn and Lois Ayash and Samuel Silver and Gregory Yanik and Pavan Reddy and Kenneth Cooke and Michael Becker and Raymond Hutchinson and James Ferrara",

year = "2005",

month = mar,

day = "1",

language = "English (US)",

volume = "3",

pages = "78--79",

journal = "Journal of Supportive Oncology",

issn = "1544-6794",

publisher = "Biolink Communications, Inc.",

number = "2 SUPPL. 1",

}

TY - JOUR

T1 - Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD

AU - Reynolds, Christopher

AU - Levine, John

AU - Uberti, Joseph

AU - Ratanatharathorn, Voravit

AU - Ayash, Lois

AU - Silver, Samuel

AU - Yanik, Gregory

AU - Reddy, Pavan

AU - Cooke, Kenneth

AU - Becker, Michael

AU - Hutchinson, Raymond

AU - Ferrara, James

PY - 2005/3/1

Y1 - 2005/3/1

UR - http://www.scopus.com/inward/record.url?scp=20144388534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144388534&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:20144388534

SN - 1544-6794

VL - 3

SP - 78

EP - 79

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

IS - 2 SUPPL. 1

ER -

Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD

ASJC Scopus subject areas

Other files and links

Cite this